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Renal cell cytokine production stimulates HIV-1 expression in chroni-
cally HIV-1-infected monocytes. Renal infiltration of human immunode-
ficiency virus type 1 (HIV-1)-infected monocytes might play an important
role in the development of HIV-associated nephropathy (HIVAN). In the
present study, we investigated the effects of cytokines produced by
cultured human mesangial cells (HMC) and proximal tubular epithelial
cells (PTEC) on HIV-1 expression in chronically HIV-1-infected
promonocytes (U1 cells). Human mesangial cells constitutively secreted
interleukin-6 (IL-6) but not tumor necrosis factor-alpha (TNF-a) into the
culture medium, whereas PTEC constitutively secreted both IL-6 and
TNF-a. Coculture of U1 cells with HMC or PTEC for 72 hours markedly
stimulated HIV-1 expression, with the p24 antigen concentration in the
coculture supernatants ranging from approximately 200 to 1850 pg/ml.
The presence of anti-IL-6 antibody in the coculture medium nearly
completely blocked HIV-1 expression in the HMC/U1 cell cocultures
(P , 0.05). Anti-IL-6 antibody and anti-TNF-a antibody blocked HIV-1
expression in the PTEC/U1 cell cocultures by 40% and 53%, respectively
(P , 0.05). Moreover, the combination of anti-IL-6 and anti-TNF-a
antibodies additively reduced coculture HIV-1 expression by 87% (P ,
0.05). We conclude that renal cell production of IL-6 and TNF-a might
provide a potent stimulus for HIV-1 expression in HIV-1-infected mono-
cytes that infiltrate the kidney, and that this may play an important role in
the pathogenesis of HIVAN.
Infection with human immunodeficiency virus type-1 (HIV-1)
can be complicated by renal disease of diverse pathology. Most
commonly, human immunodeficiency-associated nephropathy
(HIVAN) is characterized by proteinuria, focal segmental glomer-
ular sclerosis (FSGS), marked tubulointerstitial injury, and rapid
progression to end-stage renal disease [1–4]. Although the patho-
genesis of HIVAN is unknown, recent preliminary studies have
suggested that abnormal renal cytokine and chemokine produc-
tion may be important in the pathogenesis of HIVAN. Kimmel
and coworkers reported elevated levels of transforming growth
factor-beta (TGF-b), interleukin (IL)-8, and monocyte chemoat-
tractant protein-1 (MCP-I) in glomeruli and interstitium micro-
dissected from renal tissue of HIV-infected patients with FGS [5].
Transforming growth factor-b has also been detected by immu-
nohistochemistry in renal tissue from HIVAN patients [6, 7]. The
source of elevated cytokines in renal tissue of HIVAN patients is
unknown, and could involve intrinsic renal mesangial cells and
tubular epithelial cells, as well as infiltrating mononuclear cells.
Glomerular and interstitial infiltration of monocytes/macro-
phages has been identified in renal biopsy tissue obtained from
HIV-infected patients [8]. Intrarenal replication of HIV-1 in
infiltrating HIV-1-infected mononuclear cells might provide a
continuous reservoir of HIV-1 that could infect renal cells or
stimulate renal cell cytokine production, and contribute to the
development of HIVAN. Certain cytokines, including IL-6,
TGF-b, and tumor necrosis factor-alpha (TNF-a), which can be
produced by intrinsic renal cells, have been shown to up-regulate
HIV-1 replication in chronically infected mononuclear cells
[9–13]. We hypothesized, therefore, that mesangial and tubular
cells produce cytokines that stimulate HIV-1 replication in in-
fected mononuclear cells, and that this is an important mechanism
of disease development in HIVAN. To begin to test this hypoth-
esis in the present study, HIV-1 replication was measured in
chronically HIV-1-infected promonocytes (U1 cells) that were
cocultured with human mesangial or proximal tubular epithelial
cells.
METHODS
Cell culture
Human fetal mesangial cells were kindly provided by Dr.
Youngki Kim (Department of Pediatrics, University of Minnesota
Medical School). The mesangial cells were characterized, main-
tained in culture, and passaged using techniques that we have
previously described [14]. For maintenance of the mesangial cell
cultures, the culture medium consisted of RPMI-1640 supple-
mented with 10% fetal bovine serum (FBS), penicillin (100 U/ml),
and streptomycin (100 mg/ml). Because bacterial lipopolysaccha-
ride (LPS) may stimulate cytokine production in cultured cells,
the cell culture medium was routinely demonstrated to be free
from LPS contamination, using a commercial Limulus Amebocyte
Lysate Assay (Biowhitaker Inc., Walkersville, MD, USA). Mes-
angial cells between the 6th and 10th passages were used for these
experiments.
Proximal tubular epithelial cells from normal, adult human
kidney were obtained from Clonetics Corp. (San Diego, CA,
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USA) and grown in a culture medium consisting of RPMI 1640
supplemented with 1% FBS, epidermal growth factor (EGF; 10
ng/ml), and penicillin (100 U/ml) and streptomycin (100 mg/ml).
Routine testing of the culture medium indicated no detectable
levels of LPS. Proximal tubular cells in the fifth passage were used
for these experiments.
Chronically HIV-1-infected U1 cells were kindly provided by
the National Institute of Allergy and Infectious Diseases, and
were maintained in RPMI-1640 containing 10% FBS, 2 mM
glutamine, and penicillin (100 U/ml) and streptomycin (100
mg/ml). U1 cells cultured in this medium alone demonstrate little
or no HIV-1 replication.
Cytokine production
Mesangial cells were seeded in 24-well plates at a concentration
of 2 3 104 cells per well, grown to approximately 80% confluence,
and then synchronized to quiescence by a 72 hour incubation in
culture medium containing 0.5% FBS. To measure constitutive
cytokine production, the mesangial cells were then exposed for 24
hours to culture medium containing 10% FBS, and aliquots of the
cell supernatants were obtained at 6 and 24 hours and stored at
270°C until assayed for cytokine levels. To measure induced
cytokine production, some mesangial cells were exposed for 24
hours to culture medium containing LPS (10 to 100 ng/ml), and
aliquots of the cell supernatants were obtained at 6 and 24 hours
and stored at 270°C until assayed.
Proximal tubular epithelial cells were seeded in 24-well plates at
a concentration of 2 3 104 cells per well, grown to subconfluence,
and synchronized by 72 hour incubation in culture medium
without EGF. To measure constitutive cytokine production, the
tubular cells were then exposed for 24 hours to culture medium
containing EGF (10 ng/ml), and aliquots of the cell supernatants
were obtained at 6 and 24 hours and stored at 270°C until assayed
for cytokine levels. To measure induced cytokine production,
some tubular cells were exposed for 24 hours to culture medium
containing LPS (10 to 100 ng/ml), and aliquots of the cell
supernatants were obtained at 6 and 24 hours and stored at 270°C
until assayed.
Cocultures
Mesangial cells were seeded in 24-well plates at a concentration
of 2 3 104 cells per well, grown to approximately 80% confluence,
and then synchronized to quiescence by a 72 hour incubation in
culture medium containing 0.5% FBS. Cocultures of mesangial
cells and chronically HIV-1-infected U1 cells were prepared by
removing the culture medium from the quiescent mesangial cells,
and adding to each well 1 ml of culture medium containing 10%
FBS and U1 cells at a concentration of 2 3 103 cells per well. In
some coculture wells, anti-IL-6 antibody (20 mg/ml; murine mono-
clonal IgG1; R&D Systems, Minneapolis, MN, USA) was added
30 minutes prior to the addition of the U1 cells. Control wells
containing U1 cells exposed to an irrelevant, control IgG1 anti-
body or U1 cells only were also included. All samples were run in
duplicate. After 72 hours of incubation, the cell supernatants were
removed, centrifuged, and stored at 270°C until assayed for
HIV-1 p24 antigen. As we have previously described [12], mea-
surement of supernatant p24 antigen is used as an index of HIV-1
expression in U1 cells.
Proximal tubular epithelial cells were seeded in 24-well plates at
a concentration of 2 3 104 cells per well, grown to subconfluence,
and synchronized by a 72 hour incubation in culture medium
without EGF. Cocultures of proximal tubular cells and chronically
HIV-1-infected U1 cells were prepared by removing the culture
medium from the quiescent tubular cells, and adding to each well
1 ml of culture medium containing 10 ng/ml EGF and U1 cells at
a concentration of 2 3 103 cells per well. To some of the coculture
wells anti-TNF-a antibody (10 mg/ml; murine monoclonal IgG1;
R&D Systems), anti-IL-6 antibody (20 mg/ml), or both was added
30 minutes prior to the addition of the U1 cells. Control wells
containing U1 cells exposed to an irrelevant, control IgG1 anti-
body or U1 cells only were also included. All samples were run in
duplicate. After 72 hours incubation, the cell supernatants were
removed, centrifuged, and stored at 270°C until assayed for
HIV-1 p24 antigen.
Assays of cell supernatants
Interleukin-6 and TNF-a concentrations in mesangial cell and
proximal tubule cell supernatants were measured using commer-
cial ELISA kits (R&D Systems, Inc.). The sensitivity of the assay
for IL-6 was 0.7 pg/ml, and for TNF-a was 4.4 pg/ml. Coculture
supernatant concentrations of HIV-1 p24 antigen were measured
using a commercial EIA kit (Abbott Laboratories, North Chicago,
IL, USA), as we have previously described [12]. The sensitivity of
this assay is approximately 50 pg/ml, and both inter- and intra-
assay variability are less than 10%.
RESULTS
Mesangial cells incubated in culture medium containing 10%
FBS constitutively secreted IL-6 into the cell supernatant (Fig. 1).
Moreover, the supernatant concentration of IL-6 increased be-
tween 6 and 24 hours of incubation. Interleukin-6 secretion was
not maximal in the serum-stimulated cells, as LPS (10 to 100
ng/ml) induced a further dose-dependent stimulation of IL-6
Fig. 1. Mesangial cell supernatant concentrations of interleukin-6 (IL-6)
at six hours (M) and 24 hours (o) of incubation. Control cells incubated
in culture medium containing 10% fetal bovine serum (FBS) demon-
strated constitutive IL-6 secretion. Addition of lipopolysaccharide (LPS;
10 to 100 ng/ml) to the culture medium induced a dose-related increase in
IL-6 secretion. Data are mean 6 SEM of three experiments. *P , 0.05
versus control at the same time point.
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secretion (Fig. 1). By contrast, the mesangial cells did not produce
a detectable constitutive secretion of TNF-a when incubated in
medium containing 10% FBS (data not shown). Moreover, LPS
did not induce mesangial cell production of TNF-a.
Proximal tubular epithelial cells incubated in culture medium
containing EGF constitutively secreted high levels of IL-6 and
TNF-a into the cell supernatant (Fig. 2). Lipopolysaccharide (10
to 100 ng/ml) did not further increase tubular cell secretion of
either IL-6 or TNF-a (Fig. 2), possibly due to limited amounts of
LPS-binding protein in the relatively low serum (1%) culture
medium in which the tubular cells were grown.
Human immunodeficiency virus type-1-infected U1 cells incu-
bated alone in culture medium containing 10% FBS demon-
strated no detectable HIV-1 expression, as indicated by lack of
measurable supernatant p24 antigen (Table 1). Coculture of U1
cells with mesangial cells markedly up-regulated HIV-1 expres-
sion. In three separate experiments, the p24 antigen concentration
in the mesangial cell/U1 cell coculture supernatants ranged from
approximately 200 to 1000 pg/ml (Table 1). Moreover, in each
experiment, the presence of anti-IL-6 antibody in the coculture
medium blocked nearly completely HIV-1 expression in the
mesangial cell/U1 cell cocultures (Fig. 3). By contrast, a control
IgG antibody (anti-IL-1b antibody; 10 mg/ml) did not affect
HIV-1 expression in the cocultures.
Coculture of U1 cells with proximal tubular epithelial cells also
markedly up-regulated HIV-1 expression. In three separate ex-
periments, the p24 antigen concentration in the tubular cell/U1
cell coculture supernatants ranged from approximately 1200 to
1850 pg/ml (Table 1). Anti-IL-6 antibody and anti-TNF-a anti-
body blocked HIV-1 expression in the tubular cell/U1 cell cocul-
tures by 40% and 53%, respectively (Fig. 4). The combination of
anti-IL-6 antibody and anti-TNF-a antibody reduced coculture
HIV-1 expression by 87% (Fig. 4). By contrast, a control IgG
antibody (anti-IL-1b antibody) had no effect on HIV-1 expression
in the cocultures.
Fig. 2. Proximal tubule epithelial cell supernatant concentrations of
interleukin-6 (IL-6; A) and tumor necrosis factor alpha (TNF-a; B) at six
hours (M) and 24 hours (o) of incubation. Control cells incubated in
culture medium containing EGF demonstrated constitutive secretion of
both IL-6 and TNF-a. Addition of LPS (10 to 100 ng/ml) to the culture
medium did not further increase tubular cell secretion of either IL-6 or
TNF-a. Data are mean 6 SEM of two experiments.
Table 1. Human immunodeficiency virus-type 1 (HIV-1) expression in
U1 cells cocultured with either human mesangial cells (HMC) or
human proximal tubule epithelial cells (PTEC)
Sample
Supernatant p24 concentration pg/ml
Experiment 1 Experiment 2 Experiment 3
U1 cells alone -0- -0- -0-
U1 cells 1 HMC 1064 6 154 199 6 27 471 6 25
U1 cells 1 PTEC 1176 6 95 1781 6 43 1857 6 94
Data indicate mean 6 SEM of duplicate samples.
Fig. 3. p24 antigen concentrations in supernatants of human mesangial
cell/U1 cell cocultures. Anti-interleukin-6 (anti-IL-6) antibody (20 mg/ml)
almost completely inhibited HIV-1 expression. Control antibody (anti-IL-
1b; 10 mg/ml) did not affect HIV-1 expression. Data (mean 6 SEM) are a
summary of three separate experiments. *P , 0.05 vs. control.
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DISCUSSION
Recent preliminary reports have indicated increased levels of
certain cytokines and chemokines in renal biopsy tissue obtained
from HIV-1-infected patients with renal disease, suggesting that
abnormal renal cytokine and chemokine production may play a
role in the development of HIVAN [5–7]. Moreover, monocytes/
macrophages have been identified in glomeruli and renal intersti-
tium of biopsy tissue from HIV-1-infected individuals, suggesting
that renal infiltration of these immune cells may participate in the
pathogenesis of HIVAN [8]. The mechanisms by which increased
cytokine production and macrophage infiltration, alone or in
combination, might injure the kidney and lead to the development
of HIVAN are not known. Although it has not been specifically
demonstrated, it is conceivable that some of the monocytes
infiltrating the kidneys in HIV-1-infected patients are infected
with HIV-1. If so, then the results of the present study suggest that
cytokine production by intrinsic renal cells might provide a potent
stimulus for intrarenal HIV-1 expression in these infected mono-
cytes. Importantly, it has been suggested that intrarenal HIV-1
expression might cause, or at least contribute to, the development
of HIVAN [4, 15–17].
In the present study we used a coculture system to model a
possible in vivo interaction between intrinsic renal cells and infiltating
HIV-1-infected monocytes. Chronically HIV-1-infected promono-
cytes (U1 cells) were used to represent HIV-1-infected monocytes
that might infiltrate the kidney in HIV-1-infected patients. Hu-
man mesangial cells and proximal tubular epithelial cells were
used to represent intrinsic renal cells whose cytokine production
might up-regulate virus expression in HIV-1-infected immune
cells. Human mesangial cells and proximal tubular epithelial cells,
at least in culture, produce several substances that might stimulate
HIV-1 expression in U1 cells [18–20]. Because previous studies
have demonstrated that HIV-1 expression in U1 cells is markedly
stimulated by IL-6 and TNF-a [11, 12], we chose to focus on these
two cytokines.
The present results confirm observations by others that human
mesangial cells can produce and secrete IL-6 [21], and that they
do not produce TNF-a [22]. Importantly, the present study also
suggests that IL-6 is the principal mesangial cell product that can
up-regulate HIV-1 expression in infected monocytes. HIV-1
expression in mesangial cell/U1 cell cocultures was completely
blocked by anti-IL-6 antibody. In vivo, therefore, mesangial cell
IL-6 production might stimulate intraglomerular HIV-1 expres-
sion in infiltrating infected monocytes. Whether proliferating
HIV-1 in the glomerulus is important in the development of
mesangial expansion and FGS characteristic of HIVAN remains
to be determined. It should be noted, though, that HIV-1-
encoded proteins, which could accumulate in the glomerulus as a
consequence of HIV-1 expression, have been reported to facilitate
mesangial cell proliferation and matrix synthesis [23].
The present results also confirm previous findings that tubular
epithelial cells produce both IL-6 and TNF-a [19, 20]. Moreover,
both cytokines appeared to be important mediators of HIV-1
expression in the tubular cell/U1 cell cocultures. Anti-IL-6 anti-
body and anti-TNF-a antibody each reduced HIV-1 expression in
the cocultures by approximately 40 to 50%, and the combination
of the two antibodies reduced HIV-1 expression by nearly 90%.
The additive effect of the two antibodies is consistent with a
previous report indicating that IL-6 and TNF-a act via different
mechanisms to stimulate monocyte HIV-1 expression [24].
Marked tubulointerstitial injury is a primary characteristic of
HIVAN, and may play a significant role in the deterioration of
renal function in HIVAN. Although the mechanism by which
tubulointerstitial injury develops in HIVAN is not known, the
results of this study suggest that enhanced tubular cell cytokine
production, particularly of IL-6 and TNF-a, might provide a
potent stimulus for HIV-1 expression in monocytes infiltrating the
interstitium and the development of interstitial disease.
In this study we assumed that HIV-1 expression in the renal
cell/U1 cell cocultures occurred selectively in the U1 cells. It is
conceivable, though, that HIV-1 released from U1 cells might
have infected mesangial cells or proximal tubular cells, and that at
least some of the observed HIV-1 expression may have occurred
in the renal cells. While this is a possibility, previous studies have
demonstrated that mesangial cells do not become infected with
HIV-1 when exposed to the virus [25], or become infected only to
a small extent [15]. Moreover, we have found in preliminary
studies that human fetal mesangial cells do not become infected
with HIV-1 when cultured in the presence of the virus for up to
one week (unpublished data). While the HIV-1 infectivity of
proximal tubular epithelial cells has not been reported, one
previous study has demonstrated that glomerular epithelial cells
do not become infected with HIV-1 when cultured in the presence
of the virus [15].
In the present study, constitutive secretion of IL-6 by mesangial
cells, and IL-6 and TNF-a by proximal tubular epithelial cells, was
likely sufficient to cause the observed stimulation of HIV-1
expression in U1 cells cocultured with the renal cells. Chao et al
have previously exposed U1 cells to exogenous IL-6 or TNF-a at
concentrations (0.2 to 20 ng/ml and 2 to 20 pg/ml, respectively)
similar to those measured in the renal cell culture supernatants in
the present study [26]. After three days of exposure to either IL-6
or TNF-a, the U1 cell supernatant p24 antigen levels were
approximately 300 to 2000 pg/ml, comparable to the p24 antigen
Fig. 4. p24 antigen concentrations in supernatants of proximal tubule
epithelial cell/U1 cell cocultures. Anti-IL-6 antibody (20 mg/ml) and
anti-TNF-a antibody (10 mg/ml) inhibited HIV-1 expression by 40% and
53%, respectively. The combination of anti-IL-6 antibody and anti-TNF-a
antibody reduced HIV-1 expression by 87%. Control antibody (anti-IL-1b;
10 mg/ml) did not affect HIV-1 expression. Data (mean 6 SEM) are a
summary of three separate experiments. *P , 0.05 vs. control.
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levels measured in the supernatants of the renal cell/U1 cell
cocultures in the present study.
In summary, mesangial cell IL-6 production and proximal
tubular cell epithelial production of IL-6 and TNF-a were found
to markedly stimulate HIV-1 expression in chronically HIV-1-
infected promonocytes in vitro. Renal cell cytokine production in
vivo, therefore, might provide a potent stimulus for intrarenal
HIV-1 expression in HIV-1-infected monocytes that infiltrate the
kidney, and this may play an important role in the pathogenesis of
HIVAN.
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APPENDIX
Abbreviations used in this article are: EGF, epidermal growth factor;
FBS, fetal bovine serum; FSGS, focal segmental glomerulosclerosis;
HIV-1, human immunodeficiency virus type-1; HIVAN, human immuno-
deficiency virus-associated nephropathy; HMC, human mesangial cells;
IL, interleukin; LPS, lipopolysaccharide; PTEC, proximal tubular epithe-
lial cells; TGF-b, transforming growth factor beta; TNF-a, tumor necrosis
factor alpha; U1 cells, chronically HIV-1-infected promonocytes.
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